Loading clinical trials...
Loading clinical trials...
This is an expanded access program (EAP) for eligible participants designed to provide access to ACE-011.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Celgene
NCT07216443 · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and more
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
NCT07384715 · R/R AML, R/R HR-MDS, and more
NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more
NCT07578675 · Aplastic Anemia, Myelodysplastic Syndromes, and more
Celgene
Summit, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions